Human IGF-I Recombinant Protein, PeproTech
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0448473
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $249.69
About this award
The University of Virginia awarded contract A207_PO-0448473 to Life Technologies Corporation on June 12, 2026. The contract encompasses the procurement of Human Insulin-like Growth Factor I (IGF-I) Recombinant Protein manufactured by PeproTech. The total contract value is $249.69, with delivery designated to Gina M Calabrese. The line item consists of a single unit purchase at a unit price of $249.69.
Life Technologies Corporation, serving as the prime contractor, will fulfill this procurement requirement for the University of Virginia in Virginia. The contract documentation does not specify an explicit performance period; however, the award date of June 12, 2026 serves as the formal contract commencement. This purchase order represents a straightforward procurement of a specialized biological research reagent for use within the University of Virginia's research operations.
Line items
| Item | Total |
|---|---|
| Human IGF-I Recombinant Protein, PeproTech | $249.69 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0448473?
Contract A207_PO-0448473 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on June 12, 2026.
How much is contract A207_PO-0448473 worth?
Its cumulative value is $249.69.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award